Advocacy, Antipsychotic drugs, Toward better care

30 haloperidol / haldol side effects

I advocate against the inappropriate use of antipsychotics in treating people who live with dementia because I have seen first hand the devastating impact these drugs can have.

Sadly, many dementia care partners (including myself) have been forced to turn to medication out of desperation. In order to be be able to make an informed decision, it’s important to know the side effects of the medication in question. Here’s what the Alzheimer’s Organization says:

“The decision to use an antipsychotic drug needs to be considered with extreme caution. Recent studies have shown that these drugs are associated with an increased risk of stroke and death in older adults with dementia. The FDA has labeled the drugs with a “black box” warning about this risk and a reminder that they are not approved to treat dementia symptoms.”

Antipsychotics haloperidol (Haldol)queitapine (Seroquel) and risperidone (Risperdal) carry black box warnings because because they increase the risk of mortality in elderly patients with dementia. Furthermore, research shows these medications are largely ineffective in treating behavioural expressions in people who live with dementia.

Geriatricians worldwide recommend against their use, saying they should only be given as a last resort after all non-pharmacological strategies have been tried. Unfortunately, too many people who live with dementia are still prescribed these drugs which are in the majority of cases both ineffective as well as harmful.

Here are some of the side effects in elderly people from haloperidol, which is marketed under the brand name Haldol:

  1. increased risk of death
  2. catatonic-like states
  3. difficulty with speaking or swallowing
  4. inability to move the eyes
  5. loss of balance control
  6. mask-like face
  7. muscle spasms, especially of the neck and back
  8. restlessness or need to keep moving (severe)
  9. shuffling walk
  10. stiffness in arms and legs
  11. tardive dyskinesia
  12. twisting movements of the body
  13. weakness of the arms and legs
  14. dizziness
  15. hyperactivity
  16. nausea / vomiting
  17. insomnia
  18. anxiety
  19. agitation
  20. drowsiness
  21. depression
  22. lethargy
  23. headache
  24. confusion
  25. vertigo
  26. grand mal seizures
  27. exacerbation of psychotic symptoms including hallucinations
  28. sedation
  29. weight gain
  30. constipation

More and sources: here, here and here.

Giving haloperido (Haldol) to people who live with dementia and who may be unable to report the side effects they are experiencing is cruel and in many cases completely unnecessary. Read more about why drugs like haloperidol are still inappropriately prescribed to elderly people who live with dementia.

#mc_embed_signup{background:#fff; clear:left; font:14px Helvetica,Arial,sans-serif; }
/* Add your own MailChimp form style overrides in your site stylesheet or in this style block.
We recommend moving this block and the preceding CSS link to the HEAD of your HTML file. */

Subscribe to MAS now & get 5 free PDFs & a page of welcome links:

Email Address

//s3.amazonaws.com/downloads.mailchimp.com/js/mc-validate.js(function($) {window.fnames = new Array(); window.ftypes = new Array();fnames[0]=’EMAIL’;ftypes[0]=’email’;fnames[1]=’FNAME’;ftypes[1]=’text’;fnames[2]=’LNAME’;ftypes[2]=’text’;}(jQuery));var $mcj = jQuery.noConflict(true);

Take my short survey on behaviour here.

Advocacy, Antipsychotic drugs, Toward better care

will fear of alzheimer’s drive us to drugs for life?

My friend DT is worried. He’s got me worried too.  DT, recently retired from the pharmaceutical industry, sent me a link to this article “Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentum,” and included an alarming recap:

“Big pharma is going to convince an entire generation to take their toxic drugs (in huge doses) beginning early in life and potentially for life, in the hopes that it will prevent Alzheimer’s disease.

The potential profits for a strategy like this are staggering. And the potential disaster in human lives is also staggering; toxic drugs taken in large doses for decades? Even if it doesn’t kill people, it will leave them damaged somehow. And all of this using relatively the same drugs that have – as yet – failed to make a difference in Alzheimer’s!

If this isn’t the epitome of insanity, I don’t know what is. And it’s happening.”

I get the general gist,” I emailed back. “Researchers are proposing to massively increase the doses of drugs that have been shown not to work in treating Alzheimer disease thus far to see if more might be better. But a lot of the technical language is beyond me.”

“For example?” DT queried by return.

“I don’t even try to understand the various theories on plaques, tangles, taus, blah, blah, blah,” I wrote. “It’s too much for my little brain. And I don’t pay much attention to stuff related to “a cure” either, because I don’t think there’s going to be one anytime soon (i.e. not within the next 20 years). I think we need to spend a lot more time on care and doing it better.”

As an indication of the specific technical stuff that was over my head in the article, I pasted this in before I hit “reply:”

“Drug companies have erred on the side of caution in large part because antiamyloid antibodies can cause a syndrome called ARIA (Amyloid-Related Imaging Abnormalities), an inflammatory response of brain edema or microhemorrhages. Concern over this side effect has moderated as researchers accumulate more adverse event data. Most cases are asymptomatic and resolve spontaneously. New open-label extension data from the Scarlet Road and Marguerite Road trials of gantenerumab, plus a new titration model by Roche, have also increased confidence that patients will tolerate the antibody at subcutaneous doses of up to 1,200 mg.”

DT, who is known for his rather dark and satirical sense of humour, supplied a translation:

“Big pharma gets nervous when their drugs cause people’s brains to swell and bleed. They scramble back to the data to see what they can do to rescue their trillion dollar investment, all the while reassuring the public that these side effects are hard to detect and may not always be fatal. In the meantime, new experiments with people who know what drug they are taking (vs. being kept in the dark) are proving that people can take enormous doses of these drugs by under-the-skin injections without dying…. yet.”

Whoa. That’s pretty scary stuff, even for DT.

He agreed with me on a cure being unlikely, but hopes we may turn away from pharmaceuticals and more toward dietary, lifestyle, and other preventive measures. For those who get Alzheimer or a related dementia despite their best holistic efforts, his fingers are crossed for compassion-centred care.

“But stopping the BigPharma machine is going to be extremely difficult,” he cautioned. “Because now ANYONE who’s afraid of getting dementia will be persuaded to take these drugs, thanks to manufacturers’ capacity to use media and marketing models that prey on our fears.  It’s really sad.”

But not inevitable! This is one more reason to turn around the negative narrative and stigma associated with Alzheimer disease and related dementias, and to find ways to live with them before we die from fear of them.

#FightTheGoodFight

Subscribe to my free updates here.

Photo credit copyright: naumoid / 123RF Stock Photo

Advocacy, Antipsychotic drugs, Toward better care

20 caregivers answer the antipsychotic question

Anyone who reads this blog knows my position on inappropriately prescribing antipsychotic medications to people who live with dementia. Risperdal (risperidone) and Seroquel (quetiapine) robbed my mother of her ability to live her life as fully as she would have wished for her last four years. Their use on her was cruel, abusive and completely unnecessary. I’ve written extensively on this issue here.

Unfortunately, the biomedical model and the concept of challenging behaviours behind prescribing these medications is deeply entrenched; so is the profit motive for selling them. Advocating against their use is an uphill battle. The good news is we are making headway.

I was heartened when a US News article headlined: “Should antipsychotics be used for people with dementia?” was reposted on the popular Alzheimer caregiver Facebook page “TheALZTeam” where  over 90% of the commenters answered the headline question with a resounding “No!”

Here’s what caregivers said:

1 ) A pacifier, not a cure. ~ G.B

No, because antipsychotics do not cure rather than they serve to pacify people. After taking antipsychotics, the damaged brain becomes the real problem not dementia. People with dementia do not need antipsychotics. If they are used by health care staff, it means that caregivers do not understand people with whom they work and do not know how to take care of persons with dementia. This is the staff’s problem not those who have dementia or others diseases.

2 ) Make things worse, not better. ~ D.R.

No! No! No! Absolutely not! They actually made my husband psychotic and manic, they were given to make him sleep, the longer he was on them the worse he became and so they kept increasing the dose. Completely irresponsible, thankfully the doctor listened to me .

3) Legislate against them. ~ T.K.

The government should legislate that they cannot be used for people with dementia then the Doctors couldn’t be put under pressure by the nursing homes to prescribe them.

4) Train staff instead. ~ G.O.

They make them more susceptible to falls and confusion. If what is needed is more funding for training staff in behaviour modification and extra staff so they could take more time to placate residents displaying aggressive behaviour that’s what should happen, the money saved from not having to subsidise drugs would probably go a long way to funding these kinds of things.

5) They ended Mom’s life. ~ J.B

My mum passed away in March this year. She had frontal temporal lobe dementia and she had no quality of life. Strapped into a cloud chair, drugged to the eyeballs. I don’t know exactly what medications they had her on. But I feel that in the end it was them that ended her life. No autopsy was done.

6 ) Training and understanding would be more beneficial. ~ C.P.

Our mum has been diagnosed with Vascular now for over 3yrs, she has never in her life (she’s 88yrs old) taken any drugs, won’t even take a paracetamol! She is still at home and between us all (8 of us -4 live away – plus excellent carers) she is happy happy singing all day long, yes, she gets moods but they are managed with loving care, patience and understanding! I believe a lot of ppl with this illness are needlessly treated with drugs! better training and understanding of the disease would be far more beneficial than any drugs!

7) My mother deserved better. ~ J.M.

I wish they would never have to use these drugs! My poor mother was never psychotic but just because of dementia at 59, she was given these drugs. She deserved something better. These drugs did not help really. I saw how before and after taking them did not help her. Heartbreakingly, a hospice was given permission to paralyze my mother with worse drugs that took her life faster. She went back to God this year in January. She wasn’t even allowed fluids in an I.V. which simply caused dehydration. It was horrifying. I had no power over this though. God will surely give her justice. I pray for all who are suffering because of dementia and because of diseases that cause it.

8 ) I threw them in the bin. ~ K.A.

As a daughter who cared for her mother who was afflicted by this insidious disease, no medication helped. Aricept made her much worse, extremely depressed, psychotic hallucinations, absolutely apathetic and wanting to end it all. Psychotic drugs were prescribed by the doctor and I ended up throwing them in the bin. After weaning her off Aricept, we never used any medication. Nutrition, comfort, safety, love and understanding is the best medication.

9 ) I had them stopped. ~ K.S.B.

This happened to my mom! I would visit her & she was drooling out of her mouth & overly sedated. Once I was granted guardianship I had it stopped!! She is not taking any meds other than cholesterol pill & Vit. D. Also, I moved her to group home. It has been an amazing change for her well being & safety.

10 ) Look for another job. ~ J.N.

If you work someplace where someone in authority demands you contact the Dr to request medication for a “difficult” resident (even after you’ve attempted to educate them) it’s time to start looking for another job.

11) No respect for the elderly. ~ H.G.B

They prescribed these meds to my mother because they said she was aggressive & trying to care for other patients in the nursing home. I explained to the Dr that my mother wasn’t aggressive, she was Ornery & liked to play around. The reason she was trying to care for the other patients, she lost her father at the age of 14, her mother was a mess so she had to become a care giver at an early age. She also cared for my Great Grandparents & Grandparents. Also she worked in a nursing home for Many years. Her mind was back in the day of caring for others around her, especially the elderly. The Dr did not care, he said she needed this to control her behavior. My opinion, they want them to be Zombies so they are easier to care for. There is No Respect for the elderly in this country.

12 ) A nightmare. ~ S.D.O.

Dr prescribed anti-d as a sleeping pill for my mother who had Alzheimers .. Being me I tried them first …. suffered most of the side effects and got about 3 hrs sleep in 5 days . No way would I give them to mum , & thank God I tried them first ..it was a nightmare week for me on one dose.

13 ) Replace with love. ~ C.A.

My opinion is, as a wife of an Alz. Pt, sometimes they give these drugs to knock them down if they are at all “combative.” That may only happen because of the lack of training of the caregivers non training of people with Alz. Don’t give me the excuse that they have a lot of other people. Also, someone that has been labeled “Combative” it is like a scarlet letter. Showing Love can make a huge difference.

14 ) Hell nooo. ~ P.G.

Hell nooo..they were doing that to my husband i had to get a lawyer…sickening..it makes him worse ..i was his poa they weren’t supped to be giving him anything..he almost died than twice..they are in effective.

15 ) My dad got worse. ~ M.L.

My dad became psychotic and they sectioned him and put him on those meds , we lost custody , he has just got so much worse from them.

16 ) Avoid at all costs. ~ D.W

They will turn your parents onto a polypharmacy if you let them. Antidepressants and antipsychotics I would avoid at all costs.

17 ) Reduced my husband to a zombie. ~ E.S.

No no. My hubby’s mind already in a fog . Reduced him to a living zombie!

18 ) Of no help. ~ C.B.

So many people try to guilt you into using medication. They didn’t help my late Mom at all.

19 ) PLWD have enough struggles as it is. ~ D.G.

Not unless there is a proven positive effect. People with Alzheimer’s disease have enough struggles without introducing more!

20 ) No. They do more harm than good.

 

I agree with all of the caregivers above, and this is what I commented:

Antipsychotics should absolutely not be given to people who live with dementia unless all other options have been tried and have failed. Even then, they should only be given at the lowest possible dose for the shortest possible time. In addition to all the hands-on caregiver experiences and stories in the comments, there is overwhelming research evidence that these drugs are largely ineffective in people who live with dementia. Further, there is growing evidence that supports the many comments in this thread indicating that taking people off these medications improves their condition. Check the results of a landmark pan-Canadian study here.

The use of these medications must be curbed, and we must also ensure they aren’t replaced by others that are equally ineffective and even more dangerous.

Image credit: annete / 123RF Stock Photo

If you like what you’ve read, why not subscribe to my free updates?

Advocacy, Antipsychotic drugs, Toward better care

20 behavioural expressions for which antipsychotic medications are unwarranted and ineffective in people who live with dementia

Antipsychotic medications are meant to treat psychosis, not dementia. Dementia care pioneer Dr. Allen Power explains:

“What happens in the brain chemically–even when people are labeled “delusional”–is not the same in diseases that cause dementia as in classical psychosis where dopamine activity is increased, causing hallucinations and delusions. The primary action [of antipsychotics] in that disorder is achieved by blocking dopamine activity.

But no form of dementia involves heightened dopamine activity; in fact many people, including those with Lewy body dementia, have decreased dopamine activity. So dopamine-blocking drugs not only have no chemical rationale, they also are particularly toxic for such people.”

The responsive behaviour sometimes expressed by people who live with dementia is more often than not the same kind of behaviour most people who don’t have dementia would express under similar circumstances. If you don’t believe me, take this four-minute survey and see for yourself.

Not only are antipsychotics unwarranted for the behavioural expressions listed below, they are ineffective in changing the behaviour for the reason stated above. In fact, they may exacerbate the behaviour they are being inappropriately given to treat (see the side effects for Seroquel/quetiapine and Risperdal/risperidone for example). Furthermore, administering these medications results in sedation that makes it virtually impossible to find and address the real cause(s) of the behaviour.

Here is a list of behavioural expressions for which antipsychotics SHOULD NOT be prescribed for people who live with dementia because they are largely ineffective in treating the root causes:

  1. try to get out or away from wherever they are (note: often labeled as “wandering,” “exit seeking,” “elopement,” and other such terms)
  2. decline help others may think they need (note: labeled as “resists care,” or “refuses care”)
  3. go into places or try to go into places other people think they shouldn’t go (e.g. other residents’ rooms in institutions, locked rooms, private spaces, etc.; note: also often labeled as “wandering)
  4. mistake things for other things (e.g. think the TV remote is a telephone, that things that are not food are food, etc.)
  5. use things in ways they are not intended to be used (e.g. put a wet towel in the microwave to dry it)
  6. become unhappy or moody
  7. see or hear things differently than others do and are not frightened by their differing perceptions (e.g. think shadows on the wall are people; note: may be called “hallucinations”)
  8. get angry from time to time (as opposed to continuously flying into violent rages for no apparent reason)
  9. not want to do things other people believe are “for their own good” (e.g. take medication, have a bath or shower, go to sleep, get up in the morning, eat what is put in front of them, change their clothes, etc. note: also often labeled as “resists care,” or “refuses care”)
  10. believe things that are untrue (e.g. that a dead spouse, parent, friend, etc. is still alive even though they are long gone; note: these kinds of beliefs may sometimes be called “delusions”)
  11. become mildly or moderately anxious
  12. hoard or hide things
  13. call out, scream, yell, or verbalize repeatedly in other ways
  14. make noises such as clapping and tapping
  15. be unable to sit still
  16. want to stand up or walk
  17. go to the bathroom in public and/or other inappropriate places (sometimes described as “voiding at will”)
  18. take their clothes off in public
  19. eat things that aren’t food (see 4 above)
  20. curse and/or say socially inappropriate things that others may experience as being insulting or hurtful

This list is based on an excellent article by Dr. Allen Power (which also addresses the small number of situations in which the use of antipsychotics may be helpful), and a concise, practical, bullet-point fact sheet produced by Alberta Health Services  as part of their Appropriate Use of Antipsychotics (AUA) Toolkit.

Dr. Power is the author of Dementia Beyond Drugs: Changing the Culture of Care and Dementia Beyond Disease: Enhancing Well-Being, both of which I highly recommend. He is also the Schlegal Chair in Aging and Dementia Innovation at the Research Institute for Aging.

https://myalzheimersstory.com/2017/11/25/101-potential-causes-of-behaviours-by-people-living-with-dementia-that-institutional-care-staff-may-find-challenging/

https://myalzheimersstory.com/2017/11/15/the-broken-lens-of-bpsd-why-we-need-to-rethink-the-way-we-label-the-behaviour-of-people-who-live-with-alzheimers-disease/

#mc_embed_signup{background:#fff; clear:left; font:14px Helvetica,Arial,sans-serif; }
/* Add your own MailChimp form style overrides in your site stylesheet or in this style block.
We recommend moving this block and the preceding CSS link to the HEAD of your HTML file. */

Subscribe to MAS now & get 5 free PDFs & a page of welcome links:

Email Address

Take my short survey on behaviour here.

Image copyright: alexraths / 123RF Stock Photo

Advocacy, Antipsychotic drugs, Toward better care

40 risperdal side effects

I advocate against the inappropriate use of antipsychotics in treating people who live with dementia because I have seen first hand the devastating impact these drugs may have. Sadly, many dementia care partners are forced to turn to medication out of desperation. In order to be be able to make an informed decision, it’s important to know the side effects of the medication in question.

Antipsychotics risperidone (Risperdal) and quetiapine (Seroquel) carry black box warnings in the US because, like other antipsychotics, they increase the risk of mortality in elderly patients with dementia. Furthermore, recent research shows these medications are largely ineffective in treating behavioural expressions in people who live with dementia. Not surprisingly, geriatricians worldwide recommend against their use, saying they should only be given as a last resort after all non-pharmacological strategies have been tried. Unfortunately, too many people who live with dementia are still inappropriately prescribed these drugs, just as my mother was.

Risperidone (Risperdal) is an atypical antipsychotic drug that is meant to be used to treat schizophrenia and symptoms of bipolar disorder. In Canada, it is “restricted to the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type [who are] unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others.” (Bolding mine.) More information on Canada’s position here.

The United States Federal Drug Administration includes this “black box warning” on its Risperdal information sheet:

In November 2013 pharmaceutical giant Johnson and Johnson was fined $2.2 billion by the United States Department of Justice for illegally marketing three drugs one of which was Risperdal (for use in people with dementia).

Risperdal may produce side effects similar to the very conditions it is meant to alleviate in people who live with dementia.

Here are 40 of the potential side effects of Risperdal (there are more here):

  1. aggressive behaviour
  2. agitation
  3. anxiety
  4. changes in vision, including blurred vision
  5. difficulty concentrating
  6. difficulty speaking or swallowing
  7. inability to move the eyes
  8. increase in amount of urine
  9. loss of balance control
  10. mask-like face
  11. memory problems
  12. muscle spasms of the face, neck, and back
  13. problems with urination
  14. restlessness or need to keep moving (severe)
  15. shuffling walk
  16. skin rash or itching
  17. stiffness or weakness of the arms or legs
  18. tic-like or twitching movements
  19. trembling and shaking of the fingers and hands
  20. trouble sleeping
  21. twisting body movements
  22. back pain
  23. chest pain
  24. speech or vision problems
  25. sudden weakness or numbness in the face, arms, or legs
  26. constipation
  27. cough
  28. diarrhea
  29. dry mouth
  30. headache
  31. heartburn
  32. increased dream activity
  33. increased length of sleep
  34. nausea
  35. sleepiness or unusual drowsiness
  36. sore throat
  37. stuffy or runny nose
  38. unusual tiredness or weakness
  39. weight gain
  40. vomiting

Giving risperidone (Risperdal) to people who live with dementia and who may be unable to report the side effects they are experiencing is cruel and in many cases completely unnecessary. Read more about why drugs like Risperdal are still inappropriately prescribed to elderly people who live with dementia.

https://myalzheimersstory.com/2016/07/26/40-side-effects-of-seroquel/

https://myalzheimersstory.com/2017/12/09/30-haloperidol-haldol-side-effects/

#mc_embed_signup{background:#fff; clear:left; font:14px Helvetica,Arial,sans-serif; }
/* Add your own MailChimp form style overrides in your site stylesheet or in this style block.
We recommend moving this block and the preceding CSS link to the HEAD of your HTML file. */

Subscribe to MAS now & get 5 free PDFs & a page of welcome links:

Email Address

Take my short survey on behaviour here.

Advocacy, Antipsychotic drugs, Toward better care

juiced and joyful over jamda

 

It’s not every day that a non-academic, non-researcher, “nobody” without a whole bunch of letters after her name gets an article published in a professional journal. When it happens to you, well, it’s something to celebrate. At least it is when that you happens to be ME! And especially when the subject matter impacts millions of people who live with dementia around the world.

I’m delighted that the Journal of the American Medical Directors Association (JAMDA) published my editorial Efforts to Reduce Antipsychotic Use in Dementia Care are Starting to Bear Fruit, but a Lot of Work Remains to be Done in its March 2017 issue, not just because it again vindicates and validates everything I have said about my mom being inappropriately sedated with antipsychotic drugs for four years, but because it’s an indication that more members of the medical profession are beginning the see the light.

The link has been shared on twitter, Facebook and LinkedIn, generating interest and views around the world including in Australia, Canada, Ireland, United Kingdom, United States, and Spain. Yippppeee!

According to Altmetric, the article has a high attention score and is in the top 25% of all research outputs scored by the online tool. More yipppeees! A little street cred goes a long way when you’re a one-woman band marching to a different drummer as the systemic symphony plays a BigPharma tune.

The article may be viewed and downloaded at this link for free until April 15, after which it will be pay per view or via subscription to JAMDA. I invite you to take a look, and thank you for your ongoing support of my work and of MyAlzaheimersStory.com

More information on antipsychotics here.

Subscribe to my free updates here.

Image copyright: maxborovkov / 123RF Stock Photo

Advocacy, Antipsychotic drugs

drugging the elderly: how much is too much?

 

The prescription drug problem in the province of Quebec, particularly with respect to elderly people, which I first blogged about here and which is highlighted in the video below, is tragically out of hand.

A 2015 study by McGill University researchers found that “nearly 12 per cent of Quebec physicians’ prescriptions were “off-label” and of these, more than 80 per cent have no scientific evidence for non-approved use. A Montreal Gazette article on the study quoted researchers as saying “the most common medications prescribed off-label are those affecting the central nervous system specifically: antidepressants, antipsychotics and anticonvulsants. Patients taking these kind of medications reported various unwanted effects including weight gain, nausea, abdominal pain, grogginess, dizziness, loss of balance and confusion.”

My mother, who lived with dementia of the Alzheimer type, experienced all of the side effects above as a result of being given antipsychotics, which are prescribed inappropriately at an alarmingly high rate to thousands of Quebec seniors who live with Alzheimer disease. Philippe Voyer, researcher, nursing professor and supervisor of the Mentorship Clinique at the Quebec Centre for Excellence in Aging describes the levels at which antipsychotics are prescribed to elderly people who live with Alzheimer disease as “abusive.”

This is not a new issue. One of the lead researchers of the 2015 study above did a similar study in 1990, which concluded that:

“The prevalence of questionable high-risk prescribing [in Quebec], especially of psychotropic drugs, is substantial among elderly people. This may be a potentially important and avoidable risk factor for drug-related illness in elderly people.”

Things seem to have worsened since then. The 1990 and 2015 research findings are echoed in the Government of Quebec’s 2015 report “Prescription Drugs: Optimizing Costs and Use for the Benefit of the Patient and the Sustainability of the System,” which states:

“The increased use of some prescription drugs is questioned, especially in some population groups, including the elderly and children.”

Furthermore, according to a report by the Ontario Drug Policy Research Network, the use of antipsychotics among the elderly in Quebec, which was already the highest in Canada in 2009, increased by 31% over five years. Here’s what that looks like:

This is a costly practice. More important than the financial burden of this type of drug abuse, however, is the human cost, particularly in children and the elderly, and especially for extremely vulnerable elders who live with dementia, and are thus unable to speak for themselves. Far too many are inappropriately prescribed antipsychotic medications when instead they should be more humanely treated with kindness, compassion and understanding.

Subscribe to my free updates here.

Antipsychotic drugs, Resources, Toward better care

List of 15,645 US nursing homes showing percentage of residents on antipsychotics

The United States’ Medicare.gov website includes a comprehensive section called Nursing Home Compare, which contains quality of care and staffing information for all 15,600+ Medicare- and Medicaid-participating nursing homes in the country.

Among a wealth of other information, Nursing Home Compare offers data on fifteen quality measures from the “percentage of long-stay residents with a urinary tract infection,” to the “percentage of long-stay high-risk residents with pressure ulcers” for all 15,600+ facilities each month and averaged for the previous year. It also includes “the percentage of long-stay residents who received an antipsychotic.” The data on these quality measures, in addition to other ways of rating long-term care facilities (LTCFs), is updated monthly and is downloadable. However, because of the volume of information provided, it’s challenging to wade through the zip file downloads, particularly for those interested in comparing one particular parameter such as the use of antipsychotics, which is an important indicator of the overall quality of care being provided in any given facility.

To help family members, dementia care advocates and consultants choose care facilities wisely, I downloaded the Nursing Home Compare quality measure zip file, and, using excel, selected and sorted the data relevant only to the “the percentage of long-stay residents who received an antipsychotic,” to produce two easy-reference lists.

In both lists, the LTCFs are sorted alphabetically by state; then either 1) alphabetically by the name of the LTCF, or 2) in descending order based on the last four-quarter average of “the percentage of residents who received an antipsychotic” last four-quarter average as of October 2016.

Here are download links to the lists, which are excel (.xlsx) files:

The percentage of residents on antipsychotics reflects the standards of care in any given LTCF as well as the facility’s approach and philosophy with respect to dementia care (i.e. glass half full or half empty?). Faced with the heart-wrenching necessity of placing a loved one who lives with dementia in a LTCF, I believe most families would choose to place them, if possible, where they would be respected and offered the best achievable quality of life. These lists are one tool available to help US residents choose wisely. This type of information should be publicly available everywhere, just as it is in the US, so that families are better equipped to make informed decisions about dementia care options.

A cautionary note: the Nursing Home Compare data is self-reported by the facilities

More information on antipsychotics here.

Subscribe to my free updates here.

Image copyright : Oleksii Rashevskyi /123RF

Advocacy, Antipsychotic drugs, Toward better care

fear and ignorance create resistance

Fear + ignorance = resistance

Despite a growing body of research that clearly demonstrates that in the vast majority of cases medicating people who live with dementia with antipsychotic drugs does more harm than good, physicians continue to prescribe antipsychotics such as risperidone (Risperdal) and quetiapine (Seroquel) to people who live with dementia, and some family members support these decisions to prescribe.

Why do medical practitioners and family members balk at taking people who live with dementia off these dangerous and largely ineffective drugs? A variety of factors underlie their resistance.

In June 2015, the Canadian Foundation for Healthcare Improvement released the results of a pan-Canadian collaborative project aimed at reducing the use of antipsychotic medication in long-term care facilities for the elderly. The project achieved astonishing results, which I documented here. It showed, for example, that taking people off antipsychotics reduced agitation, reduced falls and reduced resistance to care.

In this clip, Kaye Phillips, Senior Director at the CFHI, and leader of the highly successful project explains two of the reasons families and medical practitioners may want to keep people who live with dementia on antipsychotic medication rather than using non-pharmacological approaches to address expressive behaviour.

More information on antipsychotics.

Subscribe to my free updates here.

Image copyright: warrengoldswain / 123RF Stock Photo

Advocacy, Antipsychotic drugs, Toward better care

what happens when care homes stop giving antipsychotics to elderly people with dementia?

In June 2015, the Canadian Foundation for Healthcare Improvement released the results of a pan-Canadian collaborative project aimed at reducing the use of antipsychotic medication in long-term care facilities for the elderly.

The project achieved astonishing results, which I documented here. Shortly after the results were released, I interviewed Kaye Phillips, Senior Director at the CFHI, and leader of the highly successful project. During that interview I asked her a simple question; she responded with a clear evidence-based answer.

More information on antipsychotics.

Subscribe to my free updates here.

Photo Credit Copyright: bialasiewicz / 123RF Stock Photo